Literature DB >> 22137928

Tolerance induced by anti-DNA Ig peptide in (NZB×NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells.

Yiyun Yu1, Yaoyang Liu, Fu-Dong Shi, Hejian Zou, Bevra H Hahn, Antonio La Cava.   

Abstract

We have previously shown that immune tolerance induced by the anti-DNA Ig peptide pCons in (NZB×NZW)F(1) (NZB/W) lupus mice prolonged survival of treated animals and delayed the appearance of autoantibodies and glomerulonephritis. Part of the protection conferred by pCons could be ascribed to the induction of regulatory T cells (T(Reg)) that suppressed the production of anti-DNA antibodies in a p38 MAPK-dependent fashion. Here we show that another effect of pCons in the induction of immune tolerance in NZB/W lupus mice is the facilitation of effector T cell suppression by T(Reg). These new findings indicate that pCons exerts protective effects in NZB/W lupus mice by differentially modulating the activity of different T cell subsets, implying new considerations in the design of T(Reg)-based approaches to modulate T cell autoreactivity in SLE. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22137928      PMCID: PMC3288892          DOI: 10.1016/j.clim.2011.11.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

2.  Modulation of p38 MAPK activity in regulatory T cells after tolerance with anti-DNA Ig peptide in (NZB x NZW)F1 lupus mice.

Authors:  Elaine V Lourenço; Claudio Procaccini; Francesca Ferrera; Noriko Iikuni; Ram P Singh; Gilberto Filaci; Giuseppe Matarese; Fu-Dong Shi; Ernest Brahn; Bevra H Hahn; Antonio La Cava
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

3.  MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus.

Authors:  C R Monk; M Spachidou; F Rovis; E Leung; M Botto; R I Lechler; O A Garden
Journal:  Arthritis Rheum       Date:  2005-04

Review 4.  Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.

Authors:  Min S Shin; Naeun Lee; Insoo Kang
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

5.  Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.

Authors:  B H Hahn; R R Singh; W K Wong; B P Tsao; K Bulpitt; F M Ebling
Journal:  Arthritis Rheum       Date:  2001-02

6.  Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.

Authors:  Ram Kumar Chowdary Venigalla; Theresa Tretter; Stefan Krienke; Regina Max; Volker Eckstein; Norbert Blank; Christoph Fiehn; Anthony Dick Ho; Hanns-Martin Lorenz
Journal:  Arthritis Rheum       Date:  2008-07

Review 7.  T-regulatory cells in systemic lupus erythematosus.

Authors:  A La Cava
Journal:  Lupus       Date:  2008-05       Impact factor: 2.911

8.  A key role of leptin in the control of regulatory T cell proliferation.

Authors:  Veronica De Rosa; Claudio Procaccini; Gaetano Calì; Giuseppe Pirozzi; Silvia Fontana; Serafino Zappacosta; Antonio La Cava; Giuseppe Matarese
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

9.  Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells.

Authors:  Kenneth J Scalapino; David I Daikh
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

10.  The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.

Authors:  John Yates; Flavia Rovis; Peter Mitchell; Behdad Afzali; J Y-S Tsang; Marina Garin; R I Lechler; Giovanna Lombardi; O A Garden
Journal:  Int Immunol       Date:  2007-06-01       Impact factor: 4.823

View more
  5 in total

Review 1.  Regulatory T Cells in SLE: Biology and Use in Treatment.

Authors:  Sophia Giang; Antonio La Cava
Journal:  Curr Rheumatol Rep       Date:  2016-11       Impact factor: 4.592

Review 2.  Tregs in SLE: an Update.

Authors:  Antonio La Cava
Journal:  Curr Rheumatol Rep       Date:  2018-02-21       Impact factor: 4.592

3.  Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4+ and CD8+ Tregs That Are Functional in Humanized Mice.

Authors:  Sophia Giang; David A Horwitz; Sean Bickerton; Antonio La Cava
Journal:  Front Immunol       Date:  2021-05-26       Impact factor: 7.561

Review 4.  T Cells in Systemic Lupus Erythematosus.

Authors:  Jacqueline L Paredes; Ruth Fernandez-Ruiz; Timothy B Niewold
Journal:  Rheum Dis Clin North Am       Date:  2021-06-16       Impact factor: 2.032

Review 5.  Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.

Authors:  Xiaoyu Wang; Yumin Xia
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.